NIT
KDNY

NumerixS Investment Technologies’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

NumerixS Investment Technologies’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,880
Closed -$117K – 1377
2016
Q3 		$117K Buy
1,880
+560
+42% +$39.6K 0.02% 800
2016
Q2 		$75K Buy
+1,320
New +$80.2K 0.01% 911

Other funds holding KDNY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NumerixS Investment Technologies's KDNY Position: Q4 2016 in Review

NumerixS Investment Technologies sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q4 2016, closing a stake of 1,880 shares — an estimated $117K sold.

NumerixS Investment Technologies first reported a position in KDNY in Q2 2016 and held it in 2 quarters. The position peaked at $117K in Q3 2016. 87 funds tracked by Wall St. Rank hold KDNY as of Q4 2016.

  • NumerixS Investment Technologies reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • NumerixS Investment Technologies sold 1,880 Chinook Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $117K.
  • NumerixS Investment Technologies first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2016 and held it in 2 quarters.
  • NumerixS Investment Technologies's Chinook Therapeutics, Inc. Common Stock position peaked at $117K in Q3 2016.
  • 87 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q4 2016.

Based on NumerixS Investment Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.